HIGHLIGHTS
- What: This study provides a review of the diagnostic criteria, incidence, cytogenetics, molecular findings, treatments, response, and prognosis of chromothripsis in myeloid malignancies.
- Who: Chromothripsis Myeloid, malignancy Complex and Chien-Yuan, Chen from the Department of Internal Medicine, Division of Hematology, National Taiwan University Hospital, No7, Chung-Shan South Road, Taipei, Taiwan have published the research: of patients with cancer [ 1 ]. However, later studies have observed chromothripsis in the genomes of patients with several types of cancer [ 2 - 6 ] and patients with congenital anomalies [ 7 9 ]. Chromothripsis is thus one of the most common mechanisms . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.